Literature DB >> 7123258

Bronchial hyperreactivity associated with tracheal gangliosides.

D K Banerjee.   

Abstract

Gangliosides, which are membrane constituents of animal cells, may be altered under various conditions that cause change in metabolism. In this study, gangliosides from tracheal and lung tissues were extracted and measured as a function of bronchial hyperreactivity in a guinea pig model of bronchial asthma. When plotted logarithmically, the data showed that tracheal gangliosides decreased with an increase in airway reactivity index, suggesting a linear relation between them. Differential analysis of tracheal gangliosides in the acute stage of bronchial hyperreactivity indicates accumulation of polysialogangliosides. These data support the hypothesis that tracheal gangliosides are intimately involved in the development of bronchial asthma.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7123258     DOI: 10.1126/science.7123258

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  3 in total

1.  Balancing life with glycoconjugates: monitoring unfolded protein response-mediated anti-angiogenic action of tunicamycin by Raman Spectroscopy.

Authors:  Maria O Longas; Ashok Kotapati; Kilari Pvrk Prasad; Aditi Banerjee; Jesus Santiago; Krishna Baksi; Dipak K Banerjee
Journal:  Pure Appl Chem       Date:  2012-07-30       Impact factor: 2.453

2.  Determining the presence of asthma-related molecules and salivary contamination in exhaled breath condensate.

Authors:  Charmion Cruickshank-Quinn; Michael Armstrong; Roger Powell; Joe Gomez; Marc Elie; Nichole Reisdorph
Journal:  Respir Res       Date:  2017-04-12

3.  Dual-Directional Regulation of Belamcanda chinensis Extract on Ovalbumin-Induced Asthma in Guinea Pigs of Different Sexes Based on Serum Metabolomics.

Authors:  Jun Liu; Jinghe Zhu; Hong Jiang; Shiliang Zhang; Si Tang; Rui Yang; Xiaoqian Dong; Liyan Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-31       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.